Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cachexia (Oncology and BASKET).php on line 2
Cachexia (Oncology and BASKET)
LE WE PMID CA
Cachexia (Oncology and BASKET)1400Kachexie (Onkologie und allg)

Anorexia nervosa

Cachexia (Oncology and BASKET)

Ghrelin

IGF1

Megestrol acetate

Melanocortin

Muscle (Physiology)

Nutrition (Neuroendocrinology)

Obesity (BASKET)

Prader Willi syndrome

2008  
1
Cancer fatigue: a neurobiological review for psychiatrists.
[18621933] Psychosomatics 49(4): 283-91 (2008)
2005  
2
2009  
3
A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.
[19244378] Am J Clin Nutr 89(4): 1173-9 (2009)
2006  
4
Cachexia: pathophysiology and clinical relevance.
[16600922] Am J Clin Nutr 83(4): 735-43 (2006)
1999  
5
Geriatric cachexia: the role of cytokines.
[10426694] Am J Clin Nutr 70(2): 183-97 (1999)
1978  
6
Origins of anorexia in neoplastic disease.
[352130] Am J Clin Nutr 31(6): 1104-7 (1978)
2008  
7
New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'.
[18296386] Asia Pac J Clin Nutr 17 Suppl 1(-): 387-90 (2008)
2001  
8
Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation.
[11141219] Ann Surg 233(1): 9-17 (2001)
1994  
9
Hypermetabolism and advanced cancer.
[8161257] Ann Surg 219(4): 323-4 (1994)
1988  
10
2005  
11
Review article: anorexia and cachexia in gastrointestinal cancer.
[16181298] Aliment Pharmacol Ther 22(7): 583-94 (2005)
1991  
12
2002  
13
Cancer anorexia-cachexia syndrome: current issues in research and management.
[11929007] CA Cancer J Clin 52(2): 72-91 (2002)
1997  
14
1999  
15
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
[10493494] Cancer Res 59(18): 4493-501 (1999)
1977  
16
Cachexia, the metabolic component of neoplastic diseases.
[324611] Cancer Res 37(7 Pt 2): 2327-35 (1977)
1951  
17
Some aspects of nitrogen and energy metabolism in cancerous subjects: a review.
[14886929] Cancer Res 11(11): 821-9 (1951)
2003  
18
2003  
19
Cancer cachexia: its correlations and causes.
[12702753] Proc Natl Acad Sci U S A 100(9): 5384-9 (2003)
2000  
20
2001  
21
Hypothalamic melanocortin signaling in cachexia.
[11459769] Endocrinology 142(8): 3288-91 (2001)
2010  
22
Oxidative stress, molecular inflammation and sarcopenia.
[20480032] Int J Mol Sci 11(4): 1509-26 (2010)
2010  
23
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.
[20164318] Am J Clin Nutr 91(4): 1143S-1147S (2010)
2005  
24
Molecular pathways leading to cancer cachexia.
[16174873] Physiology (Bethesda) 20(-): 340-8 (2005)
2011  
25
Ghrelin biology and its role in weight-related disorders.
[21712018] Discov Med 11(61): 521-8 (2011)
2009  
26
Mechanisms of cancer cachexia.
[19342610] Physiol Rev 89(2): 381-410 (2009)
2010  
27
More is better: a multimodality approach to cancer cachexia.
[20133501] Oncologist 15(2): 119-21 (2010)
2011  
28
Unintentional weight loss in older adults.
[21324857] CMAJ 183(4): 443-9 (2011)
2008  
29
Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
[19140567] Pol Arch Med Wewn 118(11): 636-44 (2008)
2010  
30
Hypothalamic mechanisms in cachexia.
[20346963] Physiol Behav 100(5): 478-89 (2010)
2010  
31
Cachexia in pancreatic cancer: new treatment options and measures of success.
[20590907] HPB (Oxford) 12(5): 323-4 (2010)
2007  
32
Cancer cachexia: pathophysiologic aspects and treatment options.
[18159985] Asian Pac J Cancer Prev 8(3): 445-51 (2007)
2010  
33
Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation.
[20473154] Curr Opin Clin Nutr Metab Care 13(4): 423-8 (2010)
2010  
34
Anabolic and catabolic pathways regulating skeletal muscle mass.
[20154608] Curr Opin Clin Nutr Metab Care 13(3): 230-5 (2010)
2010  
35
Functional consequences of sarcopenia and dynapenia in the elderly.
[20154609] Curr Opin Clin Nutr Metab Care 13(3): 271-6 (2010)
2008  
36
Epigenetic drugs in the treatment of skeletal muscle atrophy.
[18403918] Curr Opin Clin Nutr Metab Care 11(3): 233-41 (2008)
2009  
37
Dietary protein recommendations and the prevention of sarcopenia.
[19057193] Curr Opin Clin Nutr Metab Care 12(1): 86-90 (2009)
2010  
38
Interleukin 6 as a key regulator of muscle mass during cachexia.
[20871233] Exerc Sport Sci Rev 38(4): 168-76 (2010)
2011  
39
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review.
[21677406] J Genet 90(1): 165-77 (2011)
2008  
40
Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.
[18325486] Cell Immunol 252(1-2): 91-110 (2008)
2010  
41
Ghrelin in chronic kidney disease.
[20721357] Int J Pept 2010(-): - (2010)
2010  
42
Update on melanocortin interventions for cachexia: progress toward clinical application.
[20004082] Nutrition 26(2): 146-51 (2010)
2010  
43
Neuropeptides in the pathophysiology and treatment of cachexia.
[20733497] Curr Opin Support Palliat Care 4(4): 266-71 (2010)
2010  
44
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment.
[21128029] Curr Treat Options Oncol 11(3-4): 107-17 (2010)
2010  
45

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cachexia (Oncology and BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cachexia (Oncology and BASKET).php on line 92